PhotoCure ASA

PHS

Company Profile

  • Business description

    PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.

  • Contact

    Hoffsveien 4
    Oslo0275
    NOR

    T: +47 22062210

    E: [email protected]

    https://www.photocure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    101

Stocks News & Analysis

stocks

Expanding store network for ASX listed retailer

Sales growth but lack of margin expansion due to competition.
stocks

3 cheap fully franked stocks

Discounted Aussie shares that offer a tax rebate.
stocks

SpaceX jumps 19% in debut, but hurdles lie ahead

Pre-IPO holders could start selling later this summer, and earnings will be an important test.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,128.0014.600.16%
CAC 408,384.0133.140.40%
DAX 4024,894.01258.711.05%
Dow JONES (US)51,786.90584.641.14%
FTSE 10010,430.6241.10-0.39%
HKSE24,842.67124.570.50%
NASDAQ26,653.86765.022.96%
Nikkei 22569,317.503,297.464.99%
NZX 50 Index13,360.5933.28-0.25%
S&P 5007,559.49128.031.72%
S&P/ASX 2008,914.007.000.08%
SSE Composite Index4,096.4764.961.61%

Market Movers